- Karyopharm filed Chapter 11 in Southern District of Texas.
Karyopharm Therapeutics (KPTI) filed voluntary Chapter 11 petitions and entered a restructuring support agreement with lenders and noteholders. Ayrmid Ltd. will be the lead bidder in a court-supervised sale. The company secured $55M in DIP financing and expects to close the transaction in Q1 2027.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.